These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 1359717

  • 41. Topically active drugs in the treatment of peptic ulcers. Focus on colloidal bismuth subcitrate and sucralfate.
    Bianchi Porro G, Parente F.
    J Clin Gastroenterol; 1992 Apr; 14(3):192-8. PubMed ID: 1348753
    [Abstract] [Full Text] [Related]

  • 42. Drugs for peptic ulcer disease and GERD.
    Treat Guidel Med Lett; 2011 Sep; 9(109):55-60; quiz 2 p following 60. PubMed ID: 21860368
    [No Abstract] [Full Text] [Related]

  • 43. Peptic ulcer disease: an update.
    Berardi RR, Dunn-Kucharski VA.
    Am Pharm; 1993 Jun; NS33(6):26-34. PubMed ID: 8100116
    [Abstract] [Full Text] [Related]

  • 44. The end of the era of maintenance therapy for peptic ulcer disease?
    Chiba T.
    J Gastroenterol; 2000 Jun; 35(11):873. PubMed ID: 11085499
    [No Abstract] [Full Text] [Related]

  • 45. [Pharmacological efficacy of bismuth tripotassium dicitrate in peptic ulcer].
    Belousov IuB, Karpov OI, Belousov DIu, Beketov AS.
    Ter Arkh; 2007 Jun; 79(2):58-66. PubMed ID: 17460971
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. New drugs for peptic ulcers.
    Baker E, Shaffer J.
    Practitioner; 1992 Jan; 236(1510):91-4. PubMed ID: 1350860
    [No Abstract] [Full Text] [Related]

  • 48. [Drug prevention and therapy of acute gastroduodenal lesions (stress ulcers)].
    von Ritter C.
    Wien Med Wochenschr; 1992 Jan; 142(8-9):180-2. PubMed ID: 1354910
    [Abstract] [Full Text] [Related]

  • 49. Influence of the NIH Consensus Conference on Helicobacter pylori on physician prescribing among a Medicaid population.
    Thamer M, Ray NF, Henderson SC, Rinehart CS, Sherman CR, Ferguson JH.
    Med Care; 1998 May; 36(5):646-60. PubMed ID: 9596056
    [Abstract] [Full Text] [Related]

  • 50. Suppression of acid secretion in peptic ulcer disease.
    Feldman M.
    J Clin Gastroenterol; 1995 May; 20 Suppl 1():S1-6. PubMed ID: 7673607
    [Abstract] [Full Text] [Related]

  • 51. Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.
    Wagstaff AJ, Benfield P, Monk JP.
    Drugs; 1988 Aug; 36(2):132-57. PubMed ID: 3053124
    [Abstract] [Full Text] [Related]

  • 52. [Guidelines of treatment for non-bleeding peptic ulcer disease].
    Cheung DY, Jung HY, Song HJ, Jung SW, Jung HC, Korean College of Helicobacter and Upper Gastrointestinal Research, Korean Association of Gastroenterology.
    Korean J Gastroenterol; 2009 Nov; 54(5):285-97. PubMed ID: 19934610
    [Abstract] [Full Text] [Related]

  • 53. Proton-pump inhibitors or H2-receptor antagonists for Helicobacter pylori eradication-a meta-analysis.
    Holtmann G, Layer P, Goebell H.
    Lancet; 1996 Mar 16; 347(9003):763. PubMed ID: 8602022
    [No Abstract] [Full Text] [Related]

  • 54. Pylorid, H. pylori and peptic ulcer.
    Drug Ther Bull; 1996 Sep 16; 34(9):69-70. PubMed ID: 8885498
    [No Abstract] [Full Text] [Related]

  • 55. Treatment of peptic ulcers from now to the millennium.
    Pounder RE.
    Baillieres Clin Gastroenterol; 1994 Jun 16; 8(2):339-50. PubMed ID: 7949462
    [Abstract] [Full Text] [Related]

  • 56. Peptic ulcer--a new look.
    Kang JY.
    Ann Acad Med Singap; 1995 Mar 16; 24(2):218-23. PubMed ID: 7653963
    [Abstract] [Full Text] [Related]

  • 57. Gastric acid suppressants--too much of a good thing?
    Logan IC, Sumukadas D, Witham MD.
    Age Ageing; 2010 Jul 16; 39(4):410-1. PubMed ID: 20507846
    [No Abstract] [Full Text] [Related]

  • 58. [Anti-ulcer drug consumption in Spain].
    Carvajal A, García del Pozo J, del Olmo L, Rueda AM, Alvarez Requejo A.
    Aten Primaria; 1999 Mar 15; 23(4):218-21. PubMed ID: 10333606
    [Abstract] [Full Text] [Related]

  • 59. Pathogenesis and therapy of peptic ulcer disease.
    Peterson WL.
    J Clin Gastroenterol; 1990 Mar 15; 12 Suppl 2():S1-6. PubMed ID: 1978840
    [Abstract] [Full Text] [Related]

  • 60. [Anti-secretory agents modify the gastric localization of Helicobacter pylori].
    Zaterka S.
    Arq Gastroenterol; 2001 Mar 15; 38(1):1-2. PubMed ID: 11582958
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.